Diabetes Clinical Trials in Minneapolis

Showing 181-200 of 260 trials

Glucose Meter Study

NCT00782496

The purpose of this study is to evaluate if the meal marker and reminder feature of the Contour meter along with education maintains or increases frequency of testing blood sugar after meals and enables behavioral changes that may lead to improvement in glycemic control.

Diabetes Mellitus

Ascensia Diabetes Care211 participantsStarted Nov 2008

Atlanta, Georgia, United States • Minneapolis, Minnesota, United States • New York, New York, United States +1 more locations

COMPLETED< 1 mile

Support Group Surveys for Individuals Who Have Type 1 Diabetes and an Eating Disorder

NCT00818142

We propose to conduct a monthly group of persons with type 1 diabetes who also withhold insulin. Subjects will be asked to complete a 2-page survey (check-in sheet) at the beginning of each session and a 5-page survey (Diabetes and Eating Disorders Survey) on their first session and at their last session of their group.

Eating DisorderType 1 Diabetes

HealthPartners Institute16 participantsStarted Jan 2008

Minneapolis, Minnesota, United States

COMPLETED< 1 mile

Characteristics of Persons With an Eating Disorder and Type 1 Diabetes

NCT00945711

The purpose of this study is to analyze a chart audit of patients seen at Park Nicollet Eating Disorder Institute (EDI) to identify and compare general characteristics of eating disorders with type 1 diabetes patients to a matched eating disordered population without type 1 diabetes, also seen at EDI.

Eating DisorderType 1 Diabetes

HealthPartners Institute154 participantsStarted Mar 2010

Minneapolis, Minnesota, United States

Glucose Meter Study

Support Group Surveys for Individuals Who Have Type 1 Diabetes and an Eating Disorder

Characteristics of Persons With an Eating Disorder and Type 1 Diabetes

Diabetes Trials in Other Cities

Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition

Type 1 Diabetes and Eating Disorder Diurnal Glucose Patterns

Assessment of Non-Fasting vs. Fasting Lipid Measures in Diabetes Patients

Diabetic Kidney Disease: Influence of Exercise Therapy on Physical and Vascular Function.

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

An Observational Study Evaluating SYMLIN® (Pramlintide Acetate) Injection Use in Insulin Using Patients With Type 2 and Type 1 Diabetes

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

A Study Assessing Saxagliptin Treatment in Type 2 Diabetic Subjects Who Are Not Controlled With TZD Therapy Alone

Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With a Sulfonylurea

Safety and Efficacy of Saxagliptin Plus Insulin With or Without Metformin

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of Mitoglitazone in Type 2 Diabetic Patients

Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control

Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes

A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin

Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes

Other Conditions in Minneapolis